Bone Growth Stimulators Market Highlights

• The global bone growth stimulators market is set to achieve revenue of USD 3,702 million by 2032
• The bone growth stimulators market is experiencing a CAGR of 12.4% from 2023 to 2032
• In 2022, North America dominated the bone growth stimulators market with USD 479 million revenue
• The Asia-Pacific market is likely to witness CAGR of over 13% from 2023 to 2032
• Among type, the bone growth stimulation devices sub-segment generated revenue exceeding USD 639 million in 2022
• In terms of end-use, the hospitals sub-segment accounted for approximately 48% of the market share in 2022
• Increased investment by commercial organizations is a notable bone growth stimulators market trend

Bone growth stimulation (BGS) is a treatment suggested by many orthopedic surgeons to promote the recovery of fractures, particularly non-union fractures or fissures, which are fractures that do not show visible signs of healing. BGS involves using a simple device that can be placed either under or over the skin. It can also be employed to enhance bone regeneration and aid in the healing of challenging fractures or fusions by applying ultrasonic or electrical stimulation at the fracture or fusion site.

Furthermore, BGS treatment is generally considered safe and secure, with numerous BGS devices having received FDA approval for use. Many insurers recognize the medical benefits of BGS devices in certain situations and often provide coverage for their use. Patients can use these devices at home with a prescription, following the recommended daily usage hours as prescribed by an orthopedist.

Global Bone Growth Stimulators Market Dynamics

Market Drivers

• Increase in the geriatric population
• The growing incident rate of bone and joint disorder
• Growing demands for non-invasive and minimally invasive surgical treatment

Market Restraints

• Limited medical reimbursement policies for bone stimulation products
• High treatment costs related to bone morphogenetic proteins

Market Opportunities

• Customers prefer bone stimulation products for use in homecare settings
• Favorable government policies and increased investment by commercial organizations

Bone Growth Stimulators Market Report Coverage

Bone Growth Stimulators Market Insights

The main drivers of market growth in the bone growth stimulator industry include the increasing aging of the population, a rise in bone fractures, and an uptick in road accidents. Additionally, a growing incidence of arthritis, an increase in patients with type 1 diabetes, and other health issues such as obesity, vascular disease, and spinal cord injuries are contributing to the demand for these products.

Furthermore, the market is being fueled by an increase in the availability of platelet-rich plasma and bone morphogenetic proteins, a growing preference among patients for non-invasive and minimally invasive orthopedic surgeries, and the increased use of affordable bone growth stimulator devices. However, market growth may be hindered by strict certification procedures and limited clinical and medical reimbursement policies for bone stimulation devices. On a positive note, the increased adoption of magnetic and electric bone growth stimulators is expected to further boost sales in the coming years.

Bone Growth Stimulators Market Segmentation

The worldwide market for bone growth stimulators is segmented into type, application, end-use, and geography.

Bone Growth Stimulator Types

• Bone Growth Stimulation Devices
  • Capacitive Coupling (CC) Devices
  • Combined Magnetic Field (CMF) Devices
  • Electrical Bone growth stimulators
  • Pulsed Electromagnetic Field (PEMF) Devices
  • Implanted Bone growth stimulators
  • Ultrasonic Bone growth stimulators
• Bone Morphogenetic Proteins (BMP)
• Platelet-Rich Plasma (PRP) Therapy

According to the bone growth stimulators analysis, bone growth stimulation devices accounted for more than half of the market shares in 2020. These devices are designed to accelerate bone tissue growth or promote fracture healing in cases of delay or failure.

Bone growth stimulation devices can be classified into three types: electric, ultrasonic, and implanted. Electrical bone growth stimulators are used as adjunctive treatments to enhance the success of bone fusion, particularly in spinal fusion surgery.

Furthermore, human bones are living tissues with the inherent ability to heal themselves after a break or injury, much like skin. Therefore, using an electrical stimulator can aid in improving the bone healing process within the body.

Bone Growth Stimulator Applications

• Spinal Fusion Surgeries
• Oral And Maxillofacial Surgeries
• Delayed Union & Nonunion Bone Fractures
• Others

Based on the application, the spinal fusion surgery segment grew the fastest in the bone growth stimulator industry. A spinal fusion is a surgical procedure that permanently joins two or else more bones in the spinal canal to improve stability and integrity, correct a deformity, or reduce pain. Electrical bone growth stimulators are a type of treatment that aid in the body's bone healing process and are therefore this is used in spinal fusion surgeries. The increasing aging population, the increasing proportion of spinal surgeries, and the proven efficacy and safety of fusion therapy are contributing to the expansion of this segment. In addition, the increasing cases of age-related bone and spine problems and fractures are driving the market.

Bone Growth Stimulator End-Uses

• Hospitals
• Ambulatory Surgery Centers
• Others

According to the bone growth stimulators market forecast, hospitals & clinics are expected to the largest share from 2023 to 2032. The increasing number of patients admitted to hospitals with spinal injuries, traumatic injuries, car accidents, and broken bones or fractures is driving the hospital segment and clinics in the bone growth stimulator marketplace. Moreover, it is expected that the presence of advanced and trained medical professionals as well as the availability of a wide range of advanced devices and equipment, such as electric and ultrasonic bone growth stimulators, depending on the needs of the patient, will drive the growth in the hospital segment and clinics.

Bone Growth Stimulators Market Regional Outlook

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Asia-Pacific

• India
• Japan
• China
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

The Middle East & Africa

• South Africa
• GCC Countries
• Rest of the Middle East & Africa (ME&A)

Bone Growth Stimulators Market Regional Analysis

North America dominates the global market for bone growth stimulators, holding a significant share of the revenue. This dominance is attributed to the region's increasing healthcare expenditures and the rising prevalence of related bone disorders. The National Spinal Cord Injury Statistical Center estimates that in the United States, there are approximately 296,000 people with spinal cord injuries (SCI), falling within a range of 252,000 to 373,000.

As the prevalence of spinal cord injuries continues to rise, the demand for bone growth stimulators is expected to increase in the coming years. Furthermore, the growing geriatric population and the rising preference for minimally-invasive orthopedic treatments are key drivers of market growth in North America.

The Asia-Pacific region has experienced a substantial expansion in the bone growth stimulators market due to many reasons such as expanding healthcare infrastructure, an aging population, and increased knowledge of orthopedic therapies. Bone growth stimulators are medical devices that enhance bone tissue development and help in fracture repair. They're utilized to treat various orthopedic disorders, such as non-union fractures and spinal fusion surgeries.

Bone Growth Stimulators Market Players

Some of the top bone growth stimulators companies offered in our report include Arthrex, Inc., Zimmer Biomet Holdings, Inc., Isto Biologics, Colfax Corporation (Djo Global, Inc), Johnson & Johnson (Depuy Synthes), Terumo Corporation, Essex Woodlands Healthcare Partners (Bioventus Llc), Orthofix Medical Inc., Medtronic Plc., and Stryker Corporation.